Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heightened Virulence of <i>Yersinia</i> Is Associated with Decreased Function of the YopJ Protein.

Infection and immunity·2021
Same author

A colorful approach towards developing new nano-based imaging contrast agents for improved cancer detection.

Biomaterials science·2020
Same author

Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

Advanced drug delivery reviews·2014
Same author

Biodistribution and lymph node retention of polysaccharide-based immunostimulating nanocapsules.

Vaccine·2014
Same author

Construction of a preclinical multimodality phantom using tissue-mimicking materials for quality assurance in tumor size measurement.

Journal of visualized experiments : JoVE·2013
Same author

Size discrimination in rat and mouse gastric emptying.

Biopharmaceutics & drug disposition·2012

Related Experiment Video

Updated: May 13, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Radiolabeled lipid nanoparticles for diagnostic imaging.

Beth A Goins1

  • 1The University of Texas Health Science Center at San Antonio, TX Department of Radiology, Mail Code 7800, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA +1 210 567 5575 ; +1 210 567 5549 ; goins@uthscsa.edu.

Expert Opinion on Medical Diagnostics
|March 19, 2013
PubMed
Summary

Liposome radiopharmaceuticals show promise for detecting tumors and infections, but require further research for clinical approval. Careful design is crucial for effective diagnostic imaging agents.

More Related Videos

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:40

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

Related Experiment Videos

Last Updated: May 13, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:40

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

Area of Science:

  • Nanomedicine and Nuclear Medicine
  • Radiopharmaceutical Development
  • Diagnostic Imaging

Background:

  • Nanoparticles, particularly liposomes, are increasingly used in diagnostic imaging agents.
  • Liposomes radiolabeled with gamma-emitting radionuclides serve as radiopharmaceuticals for scintigraphic imaging.

Purpose of the Study:

  • Review clinical studies of liposome radiopharmaceuticals for detecting tumors, infections, and metastatic lymph nodes.
  • Discuss future applications of liposome radiopharmaceuticals in medical imaging.

Main Methods:

  • Discuss radionuclide, liposome formulation, and radiolabeling method requirements.
  • Summarize clinical studies and describe imaging procedures.
  • Explore future applications like chemodosimetry and targeted disease imaging.

Main Results:

  • Liposome radiopharmaceuticals effectively detect various tumors with high sensitivity and specificity.
  • These agents clearly identify inflammatory/infectious lesions, outperforming current agents.
  • Despite positive results, no liposome radiopharmaceutical is currently approved.

Conclusions:

  • Careful selection of radionuclide, liposome formulation, and radiolabeling is essential.
  • After-loading and surface chelation are efficient radiolabeling methods.
  • Further research is needed to overcome challenges and advance liposome radiopharmaceutical technology.